Advocacy

• Frontpage
•  
• Who we are
•  
• How we perform
•  
• How we are accountable
•  
• Downloads

• Access to health
• Responsible business practices
  • Business ethics
  • Bioethics
  • Quality
  • Responsible sourcing
  • Tax
  • Human rights
  • Advocacy
• Environment, health and safety
• People and communities
• Financial Performance
• GRI
• UN Global Compact

• Rate this page
• Send to a friend
• Print

Advocacy

• Public policies
• Changing Diabetes activities
• World Diabetes Day

With 380 million people predicted to be in need of diabetes care for the rest of their lives by 2025, this condition presents a significant challenge to socioeconomic development. Every 10 seconds two people develop diabetes, and one person dies from diabetes-related complications. In one generation, the prevalence of diabetes has increased six-fold worldwide.

While diabetes is not yet a curable disease, it can be treated and, in many cases, it can even be prevented. Novo Nordisk drives awareness of the personal and societal risks of diabetes and promotes better education of healthcare professionals and wider availability of screening for diabetes symptoms to help save lives and significant costs long term.

Novo Nordisk’s promise of Changing Diabetes underpins the company’s strategy in diabetes care and focuses on improved prevention, detection and care. It evolves around creating awareness, driving policy change and working through grassroots.

Three ambitions drive this effort:

• give priority to people with diabetes
• improve treatment outcomes and
• break the curve of the global diabetes pandemic.

Through a range of Changing Diabetes initiatives, Novo Nordisk supports the implementation of the UN Resolution on Diabetes to secure the right to diabetes care. With its resolution, adopted in December 2006, the UN encourages member countries to develop national policies for the prevention, treatment and care of diabetes in line with the sustainable development of their healthcare systems.

These activities support the campaign 'Unite for Diabetes', led by the International Diabetes Federation, with an ambitious effort to change the future of diabetes. Particular attention is given to the needs of children and youth, their families and social networks.

Working in partnerships to change diabetes, the company is engaged in a host of activities, orchestrated globally or run by affiliates in local communities. These include the International Diabetes Federation, the Juveline Diabetes Research Foundation, ISPAD and the Global Alliance for Women's Health.

Also internally, Novo Nordisk is driving awareness campaigns for healthy lifestyles. The global NovoHealth programme offers employees access to healthy foods, exercise, health checks and a non-smoking environment.

Back to top